Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin to Prevent Bronchopulmonary Dysplasia in Ureaplasma-positive Preterm Infants
KCT0002373Phase 2Recruiting
- Sponsor
- Asan Medical Center
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azithromycin in bronchopulmonary dysplasia (BPD), ureaplasma infection, sponsored by Asan Medical Center. Started Jun 2017; status: recruiting.
02
Drugs
azithromycin
03
Conditions
bronchopulmonary dysplasia (BPD)ureaplasma infection
Beyond the preview
Go deeper on KCT0002373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0002373.